GlassScriptPhysician profile
Felix Cheung
NPI 1184913527
$9,546.55
in general payments reported to CMS, 2019-2025
10 companies · $854 in 2025
The $854 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,812 · 2020: $123 · 2021: $1,658 · 2022: $2,703 · 2023: $1,929 · 2024: $467 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,451 · Travel and Lodging: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.55 |
| Travel and Lodging | $799.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,713.39 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, General - Erectile Dysfunction, Ams 700 |
| Procept Biorobotics Corporation | $3,659.08 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $1,344.64 | 2021-2024 | Bulkamid, Axonics |
| Medtronic, INC. | $196.63 | 2022 | |
| Profound Medical Corp. | $172.03 | 2025 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $154.50 | 2025 | Adstiladrin |
| Olympus America INC. | $143.13 | 2025 | Itind System |
| Innovation Technologies INC | $127.06 | 2023 | Irrisept |
| Valencia Technologies Corporation | $36.09 | 2025 | Ecoin Device Kit |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.